Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Capstone Therapeutics Corp. (CAPS) had Revenue of $7.90M for the most recently reported fiscal quarter, ending 2025-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-03-31

Income Statement Financials
Revenue	$7.90M
Net Income	$-2.43M
Cost of Goods Sold	$6.57M
Gross Profit	$1.32M
Operating Expenses	$9.33M
Operating Income	$-1.43M
Non-Operating Income/Expense	$-0.30M
Pre-Tax Income	$-1.73M
Normalized Pre-Tax Income	$-1.73M
Income after Taxes	$-1.73M
Income from Continuous Operations	$-1.73M
Consolidated Net Income/Loss	$-1.73M
Normalized Income after Taxes	$-1.73M
EBIT	$-1.43M
EBITDA	$-1.31M
Weighted-Average Shares Outstanding (Basic)	5.19M
Weighted-Average Shares Outstanding (Diluted)	5.19M
Earnings per Share (EPS) (Basic)	$-0.47
Earnings per Share (EPS) (Diluted)	$-0.47
Balance Sheet Financials
Current Assets	$16.71M
Property, Plant, and Equipment	$1.53M
Long-Term Assets	$35.50M
Total Assets	$52.21M
Current Liabilities	$14.66M
Long-Term Debt	$7.54M
Long-Term Liabilities	$10.58M
Total Liabilities	$25.24M
Common Equity	$26.97M
Tangible Shareholders Equity	$3.62M
Shareholders Equity	$26.97M
Common Shares Outstanding	5.19M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-2.29M
Cash Flow from Investing Activities	--
Cash Flow from Financial Activities	$4.02M
Beginning Cash	$0.01M
End Cash	$1.74M
Increase/Decrease in Cash	$1.73M
Stock-Based Compensation	--
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.14
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.22
Debt to Equity Ratio	0.60
Gross Margin	16.77%
Operating Margin	-18.08%
EBIT Margin	-18.08%
EBITDA Margin	--
Pre-Tax Profit Margin	-21.88%
Profit Margin	-30.80%
Free Cash Flow	$-2.29M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.15
Inventory Turnover	0.67
Receiveable Turnover	1.75
Days Sales in Receivables	51.48
Return on Equity	-6.41%
Return on Tangible Equity	-47.70%
Return on Assets	-3.31%
Return on Investments	-5.01%
Book Value Per Share	$5.20
Free Cash Flow per Share	$-0.44
Operating Cash Flow per Share	$-0.44

Data from Zacks Investment Research, Inc.